Xifaxan at a glance
Xifaxan is a brand name for rifaximin, an intestinal antibiotic with limited absorption into the bloodstream. Its action is mainly local to the gut, which distinguishes it from many antibiotics used for systemic infections. The appropriate use of Xifaxan depends on the diagnosed condition, the strength supplied, and the treatment plan issued by a qualified prescriber.
In Norway, medicines are regulated to protect patients from unsuitable treatment, counterfeit products, and avoidable antibiotic resistance. Product availability, authorised indications, and pack sizes can change, so the current Norwegian product information should be checked before dispensing. A pharmacist can also help confirm whether a supplied product is suitable for the prescription presented.
This page provides general product information and does not replace medical assessment. Persistent diarrhoea, fever, blood in stools, marked dehydration, jaundice, confusion, or severe abdominal pain require prompt medical evaluation. Antibiotics should not be started simply because gastrointestinal symptoms are uncomfortable or inconvenient.
Active ingredient and origin of rifaximin
The active ingredient in Xifaxan is rifaximin, a semisynthetic derivative of rifamycin antibiotics. Rifamycins originated from compounds produced by a soil bacterium and were subsequently developed into medicines with different antibacterial properties. Rifaximin was designed to remain predominantly within the gastrointestinal tract after oral administration.
Its development built on knowledge of earlier rifamycin medicines, including their ability to interfere with bacterial genetic processes. The low systemic absorption of rifaximin made it of interest for selected bowel-related conditions where local action is clinically useful. This characteristic does not mean that it is risk-free or appropriate for every type of diarrhoea.
Modern use of rifaximin is supported by product-specific research and regulatory review rather than by its antibiotic family alone. Different countries may authorise different indications and formulations. Patients in Norway should rely on the indication and directions stated on their own medicine label and prescription.
What Xifaxan may be used for
Rifaximin may be prescribed for particular gastrointestinal conditions associated with susceptible bacteria. Depending on the authorised local product and clinical assessment, uses may include certain forms of traveller’s diarrhoea, prevention of recurrent episodes of hepatic encephalopathy, or management of diarrhoea-predominant irritable bowel syndrome. These uses are not interchangeable, and each has different dosing and follow-up requirements.
Not all diarrhoea is bacterial, and an antibiotic will not treat viral gastroenteritis, food intolerance, inflammatory bowel disease, or many parasitic infections. Symptoms with fever, visible blood or mucus, severe illness, or recent hospital exposure need medical review before treatment. A clinician may request testing or recommend rehydration and observation instead of an antibiotic.
For hepatic encephalopathy, rifaximin is typically part of a broader care plan supervised by a specialist. It may be used alongside other treatments rather than as a replacement for them. New drowsiness, personality change, tremor, or confusion in a person with liver disease should be treated as urgent symptoms.
How rifaximin works in the intestine
Rifaximin blocks a bacterial enzyme involved in making RNA, a molecule bacteria need to produce proteins and multiply. This reduces the growth of susceptible bacteria in the bowel. The medicine does not work against every organism, and resistance can occur when antibiotics are used unnecessarily or incorrectly.
Only a small amount of a usual oral dose reaches the circulation in most people, while much of the medicine acts in the intestinal lumen. This local distribution helps explain why rifaximin is used for selected gut-related indications. However, absorption may be higher when the intestinal lining is damaged or when significant liver impairment is present.
The benefit of treatment should be assessed in relation to the underlying diagnosis and symptom pattern. If symptoms worsen or fail to improve within the period advised by the prescriber, the patient should contact a healthcare professional. Do not extend a course, repeat a previous course, or share tablets with another person.
Scientific evidence and clinical limits
Clinical research has evaluated rifaximin in specific patient groups, with outcomes varying by indication and formulation. Evidence generally supports its use only when patients meet defined clinical criteria. A positive study result for one condition should not be assumed to apply to other bowel symptoms.
Research also recognises the importance of antimicrobial stewardship. Limiting antibiotics to appropriate indications helps preserve their usefulness and reduces the chance of adverse effects such as antibiotic-associated diarrhoea. Healthcare professionals weigh expected benefit against individual factors including recent antibiotic exposure and infection history.
Questions about whether Xifaxan is effective for a particular symptom should be discussed with a prescriber or pharmacist. Personal medical history, travel history, liver function, other medicines, and severity of symptoms can affect that decision. Reliable treatment is based on diagnosis, not on self-selection from search results.
Forms, strengths, and prescribed dose
Xifaxan is commonly supplied as oral tablets, although marketed strengths and authorised packs differ between countries. Strengths used for acute intestinal infections may differ from those used for longer-term prevention of hepatic encephalopathy or for other approved indications. The packaging and dispensing label are the definitive source for the strength and schedule supplied to an individual patient.
Take the medicine exactly as directed, at the specified times and for the prescribed duration. Tablets can generally be taken with or without food unless the label or prescriber gives different instructions. Swallow them with water rather than crushing or altering them unless a pharmacist confirms that doing so is appropriate.
If a dose is missed, follow the instructions provided with the medicine or seek pharmacist advice. In general, a missed dose should not lead to taking two doses together unless a healthcare professional specifically advises it. Keeping a simple dosing routine can reduce accidental omissions and duplicate doses.
How long Xifaxan acts and remains in the body
The clinical duration of Xifaxan depends on why it has been prescribed. Some people may notice improvement in certain symptoms during a short course, while other indications involve ongoing treatment intended to reduce recurrence risk. Symptom improvement does not establish that an infection has resolved or that treatment can be stopped early.
Rifaximin is poorly absorbed and is eliminated largely through the gastrointestinal tract in faeces. The small absorbed portion is generally cleared relatively quickly, but the exact time for a medicine to leave the body varies with dose, health status, liver function, and intestinal disease. A prescriber can provide individual guidance where timing matters for a procedure, pregnancy planning, or another treatment decision.
Because rifaximin acts mainly in the gut, its intended antibacterial activity is linked to its presence in the intestinal tract rather than a prolonged blood concentration. Do not use estimated elimination times to change a prescribed regimen. Continue, stop, or restart treatment only after receiving appropriate clinical advice.
Side effects and allergic reactions
Possible side effects include nausea, abdominal discomfort, bloating, headache, dizziness, or changes in bowel habit. These effects may also resemble the condition being treated, so a pharmacist or prescriber can help assess persistent or troublesome symptoms. Report unexpected effects, especially if they interfere with eating, hydration, sleep, or daily activity.
Allergic reactions are uncommon but can be serious. Seek urgent medical help for swelling of the face, lips, tongue, or throat; breathing difficulty; widespread rash; blistering; or faintness. People with a known allergy to rifaximin, rifampicin, rifabutin, or another rifamycin antibiotic should tell a clinician before taking Xifaxan.
Any antibiotic can be associated with significant diarrhoea caused by disruption of normal gut bacteria. Watery or bloody diarrhoea, severe cramps, or fever during treatment or after finishing it should be assessed promptly rather than treated with leftover medication. This is particularly important after recent healthcare contact or repeated antibiotic courses.
Who should avoid or use Xifaxan cautiously
Xifaxan should not be used by anyone with known hypersensitivity to rifaximin, other rifamycin antibiotics, or a relevant ingredient in the supplied tablet. It may also be unsuitable where there is suspected invasive intestinal infection, especially when fever or blood in the stool is present. A clinician should determine the cause of symptoms before selecting an antibiotic.
People with significant liver disease need individual assessment because systemic exposure to rifaximin can be higher. Pregnancy and breastfeeding require a careful discussion of potential benefits, uncertainties, and available alternatives. Tell the prescriber about kidney or liver conditions, past antibiotic-related colitis, and any history of severe drug reactions.
Age limits depend on the indication, formulation, and national authorisation. Some rifaximin uses are primarily established for adults, while paediatric treatment requires specialist or product-label guidance. A child or adolescent should not receive an adult’s remaining tablets or a medicine prescribed for another family member.
Interactions with alcohol, food, and medicines
There is no reliable reason to use alcohol as part of treatment with Xifaxan. Alcohol can worsen dehydration, diarrhoea, abdominal symptoms, and impaired judgement, and it is particularly unsuitable for people with liver disease. Avoiding alcohol during an acute illness is a prudent approach unless a clinician has advised otherwise.
Although rifaximin has low systemic absorption, interactions remain possible in some circumstances. Tell the prescriber and pharmacist about all prescription medicines, non-prescription treatments, herbal products, vitamins, and supplements. This is especially important for medicines with narrow safety margins or treatments used for liver disease, infection, or blood clot prevention.
Food restrictions are not generally the defining feature of rifaximin treatment, but product-specific instructions should be followed. Maintain fluid intake when diarrhoea is present, using oral rehydration measures where appropriate. Severe dehydration, inability to retain fluids, or reduced urination needs medical assessment.
Dependence, misuse, and antibiotic resistance
Xifaxan is not considered a medicine that causes physical dependence or addiction in the way that sedatives, opioids, or certain stimulants can. It does not create a recognised craving-driven pattern of use. Nevertheless, it should only be taken for a valid medical indication and under appropriate supervision.
Misuse of antibiotics can contribute to resistance, meaning bacteria may become harder to treat in the future. Taking rifaximin for unconfirmed symptoms, keeping unused tablets, or repeating old treatment plans increases that risk. Complete or stop the course only according to the instructions from the responsible healthcare professional.
Patients who repeatedly experience digestive symptoms should seek assessment for the cause rather than repeatedly self-treating. Recurrent symptoms can have infectious, dietary, inflammatory, medication-related, or functional explanations. A correct diagnosis is safer and more useful than continued antibiotic exposure.
Overdose and urgent concerns
Taking more Xifaxan than prescribed may increase the chance of side effects even though absorption is usually limited. The appropriate response depends on the amount taken, the person’s age and health, and whether other medicines or alcohol were involved. Keep the medicine pack available so healthcare staff can identify the exact strength and formulation.
If an overdose is suspected, contact a poison information service, out-of-hours medical service, pharmacist, or emergency service in Norway without delay. Seek emergency help immediately for collapse, breathing problems, severe rash, seizures, marked confusion, or inability to stay awake. Do not induce vomiting unless specifically instructed by a medical professional.
For a small accidental extra dose without symptoms, obtain timely advice rather than guessing what to do next. Do not compensate by skipping several future doses unless a clinician directs this. Recording the time and quantity taken can help a healthcare professional provide accurate guidance.
Alternatives to Xifaxan
Alternatives depend entirely on the condition being treated. For uncomplicated diarrhoea, rehydration, dietary adjustment, or observation may be more appropriate than an antibiotic. Where an infection is confirmed, another antimicrobial may be chosen according to likely cause, local resistance patterns, allergies, and test results.
For irritable bowel symptoms, alternatives may include dietary strategies, fibre adjustment, gut-directed therapies, or medicines chosen for the dominant symptom. These options should be considered with a clinician because the best approach differs between constipation-predominant, diarrhoea-predominant, and mixed symptoms. Sudden change in bowel habit, weight loss, rectal bleeding, or night-time symptoms requires medical evaluation.
For hepatic encephalopathy, treatment choices and monitoring are specialist-led. Management may include identifying triggers, addressing constipation or infection, and using medicines selected for the individual patient. Never substitute or discontinue an established liver-disease regimen without specialist advice.
Xifaxan price in Norway and safe supply
Xifaxan price in Norway can vary according to tablet strength, pack size, reimbursement eligibility, dispensing fees, and the pharmacy’s current supply arrangements. Prices displayed by other digital pharmacies are illustrative rather than a guarantee of what a particular patient will pay. A legitimate pharmacy should show clear product, pack, and delivery information before payment is completed.
In Norway, prescription medicine supply must follow applicable pharmacy and prescribing rules. A responsible pharmacy verifies a valid prescription where required and does not present prescription medicines as routine self-service products. Claims that a prescription antibiotic can always be obtained without clinical review should be treated with caution.
Choose a pharmacy that provides identifiable contact details, professional pharmacist support, secure payment processes, and transparent terms. Avoid sellers that conceal the source of their medicines, promise unrealistic results, or omit safety information. Counterfeit or improperly stored antibiotics can pose serious health risks.
Benefits of using a digital pharmacy
When permitted by Norwegian regulations and supported by a valid prescription, a digital pharmacy can make medicine access more convenient. Patients may compare available pack information, request pharmacist support, and arrange delivery without an unnecessary trip when they are unwell. Convenience should never replace a clinical consultation when symptoms suggest a serious illness.
Buy Xifaxan online only through a pharmacy that follows appropriate verification and dispensing procedures. Secure services protect personal information and make it easier to review the order details before dispatch. The medicine supplied should match the prescribed strength, quantity, and directions.
Digital ordering can also assist with practical medication planning, particularly for patients who need a repeat supply authorised by their prescriber. Delivery timing should be considered carefully so that treatment is not interrupted. Do not rely on an unverified overseas seller when a treatment is needed urgently.
How to place an order and follow delivery
Start by selecting the prescribed Xifaxan product and submitting the prescription information requested by the pharmacy. Review the strength, number of tablets, delivery address, and contact details carefully before confirming payment. If the prescription is unclear, expired, or does not match the chosen product, the pharmacy should pause dispensing and seek clarification.
After the order is accepted, the pharmacy may send confirmation and dispatch updates through its secure ordering system. Package tracking is normally available when the selected delivery service supports it, allowing the customer to follow the parcel’s progress. Tracking information should be used discreetly because it may relate to a health purchase.
Check the parcel promptly on arrival and ensure the outer packaging is intact. Confirm that the medicine name, strength, quantity, and patient label correspond with the prescription before taking the first dose. Contact the pharmacy rather than using the medicine if there is damage, an apparent discrepancy, or a concern about storage during delivery.
Storage and responsible disposal
Store Xifaxan in its original packaging, away from children, pets, moisture, and excessive heat. Follow the storage temperature and expiry date printed on the carton and patient leaflet because these instructions apply to the specific product supplied. Do not keep tablets in a bathroom, vehicle, or other place with frequent humidity or temperature changes.
Do not use medicine beyond its expiry date or if tablets appear damaged, discoloured, or improperly packaged. A pharmacist can advise what to do if a delivery has been exposed to unusual conditions or if the seal appears compromised. Keep the label attached so the product can be identified correctly.
Unused or expired Xifaxan should be returned to a pharmacy for safe disposal where this service is available. Do not flush tablets down the toilet or place them loosely in household waste. Proper disposal helps prevent accidental use and reduces unnecessary release of medicines into the environment.
When to seek further medical advice
Contact a healthcare professional if symptoms do not improve as expected, recur soon after treatment, or become more severe. Seek urgent assessment for high fever, blood in stool, severe dehydration, persistent vomiting, yellowing of the skin or eyes, or altered mental state. These signs may indicate a condition that requires treatment beyond Xifaxan.
Before each new course, inform the prescriber about any side effects experienced during previous rifaximin treatment. This includes rash, significant diarrhoea, abdominal pain, allergic symptoms, and changes in other medicines. Accurate information supports safer prescribing and helps determine whether an alternative is more appropriate.
Xifaxan can be an important medicine for selected patients when used correctly. Its value lies in targeted treatment, verified supply, and follow-up that reflects the underlying condition. For individual questions about suitability, dosing, or access in Norway, consult a qualified prescriber or pharmacist.
Frequently Asked Questions
Can Xifaxan be used for recurring symptoms?
Whether another course of Xifaxan is appropriate depends on the diagnosed condition, symptom pattern, previous response, and the clinician’s assessment. Recurrent diarrhoea, abdominal symptoms, or confusion associated with liver disease can also have causes that need separate evaluation.
Does Xifaxan treat viral stomach infections?
No. Xifaxan contains rifaximin, an antibacterial medicine, so it does not treat viral gastroenteritis such as norovirus. Persistent diarrhoea, fever, blood in the stool, or dehydration should be assessed rather than treated on the assumption that an antibiotic is needed.
Can Xifaxan be taken during pregnancy or while breastfeeding?
Pregnancy and breastfeeding require an individual benefit-risk assessment by a prescriber. Tell the clinician if you are pregnant, planning pregnancy, or breastfeeding before starting Xifaxan, and do not stop or start treatment without professional guidance.
Is Xifaxan suitable for children and teenagers?
Suitability depends on the person’s age, diagnosis, formulation, and local authorisation. A paediatric clinician or pharmacist should confirm whether rifaximin is appropriate; adult directions should not be applied to a child.
What should I do if symptoms do not improve after taking Xifaxan?
Contact the prescriber if symptoms persist, worsen, or return soon after treatment. Seek prompt medical attention for warning signs such as significant dehydration, high fever, severe abdominal pain, bloody stools, rash with swelling, or breathing difficulty.
Can Xifaxan affect laboratory tests or medical assessments?
Tell healthcare professionals that you are taking or have recently taken Xifaxan when discussing new symptoms or arranging tests. This helps them interpret your clinical situation and decide whether further stool tests, blood tests, or other assessment is needed.
Why is it important to complete the prescribed Xifaxan course?
Use Xifaxan exactly for the duration and schedule prescribed, even if symptoms improve earlier, unless a clinician tells you otherwise. Changing the course independently may reduce treatment effectiveness or delay recognition of a different cause of symptoms.
Can I drive or operate machinery while taking Xifaxan?
Xifaxan is not generally expected to impair alertness for most people, but illness itself or an individual reaction such as dizziness can affect safe driving. Avoid driving or hazardous tasks if you feel unwell, dizzy, or unable to concentrate.
What information should I give the pharmacist before starting Xifaxan?
Provide your current medicines, non-prescription products, supplements, allergies, relevant liver or kidney conditions, and any recent antibiotic treatment. Also mention if you have severe diarrhoea, fever, blood in the stool, or have recently been in hospital.
How can patients in Norway verify that Xifaxan is supplied safely?
Use a pharmacy that is authorised to dispense medicines in Norway and follow its prescription-verification process where required. Check that the pack is sealed, labelled for the intended patient, and accompanied by appropriate pharmacy information; contact the pharmacy before use if anything appears unclear.
Pharmacist Review
The current Xifaxan page has been professionally reviewed for medical accuracy, balanced safety information, and relevance to patients in Norway.
| Reviewer | Professional details |
|---|---|
| Ingrid Solberg | Master of Pharmacy (MPharm), HPR No. 87361542 |
| Professional reference | Norwegian Directorate of Health |
| Review date | 24 February 2025 |
This review supports clear, responsible information about rifaximin, including prescribed use, precautions, adverse effects, and the importance of following individual treatment instructions.
Medical disclaimer: This material is for informational purposes only and does not replace consultation with a doctor or other qualified healthcare professional.
Pharmacy Location and Opening Hours
For Xifaxan, visit our pharmacy at Jernbanetorget 4, 0154 Oslo, Oslo, Norway.
| Days | Opening hours |
|---|---|
| Monday–Friday | 07:00–21:00 |
| Saturday | 09:00–18:00 |
| Sunday | 10:00–18:00 |